TWUIX
Price
$114.00
Change
-$0.09 (-0.08%)
Updated
Dec 3 closing price
Net Assets
27.57B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

TWUIX vs VIGRX

Header iconTWUIX vs VIGRX Comparison
Open Charts TWUIX vs VIGRXBanner chart's image
American Century Ultra® I
Price$114.00
Change-$0.09 (-0.08%)
VolumeN/A
Net Assets27.57B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
TWUIX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
TWUIX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TWUIX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. TWUIX (27.6B). VIGRX pays higher dividends than TWUIX: VIGRX (0.30) vs TWUIX (0.00). TWUIX was incepted earlier than VIGRX: TWUIX (29 years) vs VIGRX (33 years). TWUIX (0.72) is less costly to investors than VIGRX (0.17). VIGRX is a more actively managed with annual turnover of: 11.00 vs. TWUIX (7.00). VIGRX has a lower initial minimum investment than TWUIX: VIGRX (3000) vs TWUIX (5000000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. TWUIX (9.58). VIGRX return over 5 years is better than : 99.11 vs. TWUIX (44.73).
TWUIXVIGRXTWUIX / VIGRX
Total Expense Ratio0.670.17394%
Annual Report Gross Expense Ratio0.720.17424%
Fund Existence29 years33 years-
Gain YTD14.60719.76474%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets27.6B357B8%
Annual Yield % from dividends0.000.30-
Returns for 1 year9.5818.4952%
Returns for 3 years66.57110.8260%
Returns for 5 years44.7399.1145%
Returns for 10 years193.62349.1355%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT